tdcs&adhd: ADHD Electrophysiological Subtypes and Implications in Transcranial Direct-current Stimulation

Sponsor
Spanish Foundation for Neurometrics Development (Other)
Overall Status
Completed
CT.gov ID
NCT01649232
Collaborator
(none)
60
1
2
6
10

Study Details

Study Description

Brief Summary

In the present study the aim is to examine whether transcranial direct-current stimulation (tDCS) generated excitability changes and induce modifications of functional cortical architecture in Attention Deficit Hyperactivity Disorder (ADHD) patients. To achieve this, the investigators used an event-related potential (ERP) analysis based on 20 channel EEG recordings in ADHD subjects before and after bipolar tDCS-anode stimulation over F3/F4 or T5/T6 or P4/P3, during resting state and measure clinical scores and visual CPT tasks changes. Time courses and topography of independent component visual ERPs were compared before and after tDCS.

Condition or Disease Intervention/Treatment Phase
  • Device: Active tDCS
Phase 3

Detailed Description

Important advances in the understanding of ADHD pathophysiology, such fMRI studies showing a focal frontotemporal loops dysfunction in brain activity, suggest that frontal brain stimulation might be helpful for the treatment of ADHD. In a recent study of Lyon's university with tDCS they concluded that tDCS is "cheaper and easier-use than transcranial magnetic stimulation (TMS) and the impact on symptomatology seems larger (impact on negative symptoms of schizophrenic patients) and longer (at least 3 months duration) than that TMS currently permits. It is possible that tDCS could in the future be used at home by patients themselves. The efficacy of tDCS depends of parameters like electrode position and current strength.

In this trial, The investigators investigated the effects of 12 days of anodal stimulation of the left dorsolateral prefrontal cortex in ten patients with ADHD (aged 8 +/- 3 years). tDCS was applied through a saline-soaked pair of surface sponge electrodes (35 cm2). The anode electrode was placed over F3/F4 or T5/T6 or P4/P3(based on the 10-20 International EEG System) of each subject. The cathode was placed over the contralateral mastoid area. A constant current between 1.1 and 2.0 mA was applied for 25 min/day (administered for 12 alternated days).

Prior to the first session, ADHD subjects were asked to complete and return a series of questionnaires, including the Conners Brief Symptom Inventory, a health history questionnaire, and the QEEG questionnaire. Subjects were then tested in a first session which lasted approximately three hours. During this period, a comprehensive structured clinical interview was carried out, comprising of an assessment of current and past ADHD symptoms, the history of problems at school, the past psychiatric history (including drug and medication use), as well as past and present comorbidities. Subsequently, EEG data was acquired. EEG data was first recorded while the subject was in eyes-closed and eyes-open resting conditions, lasting four minutes each. Then data was recorded while subjects performed a visual continuous performance task (VCPT). The VCPT took approximately 22 minutes to complete. In addition, subjects randomly performed either an auditory or an emotional continuous performance task.

The control group had a shortened procedure. Subjects were tested in a single session lasting approximately two and a half hours. During this period, a series of questionnaires (Brief Symptom Inventory, Health History questionnaire, Current Symptoms Scales) were filled out and thereafter, EEG data was acquired. Subsequently, a working memory task, which is not relevant here, was administered.

EEG was recorded using a Mitsar 201 19-channel electroencephalographic system. The input signals referenced to the linked ears were filtered between 0.5 and 50 Hz and digitized at a sampling rate of 250 Hz. Impedance was kept below 5 kOhm for all electrodes. Electrodes were placed according to the International 10-20 system using a electrode cap. Quantitative data was calculated using WinEEG software. Linked ears reference montage was changed to average reference montage prior to data processing. Eye-blink artefacts were corrected by zeroing the activation curves of individual ICA component score responding to eye blinks. In addition, epochs of the filtered electroencephalogram with excessive amplitude (>100 μV) and/or excessive fast (>35 μV in 20 to 35 Hz band) and slow (>50 μV in 0 to 1 Hz band) activity were automatically marked and excluded from further analysis. Finally, EEG was manually inspected to verify artefact removal.

Behavioral task

The VCPT is a modification of the visual two-stimulus GO/NOGO paradigm. Three categories of visual stimuli were selected: 20 pictures of animals, 20 pictures of plants, and 20 pictures of humans (presented together with an artificial "novel" sound). The trials consisted of presentations of pairs of stimuli: animal-animal (GO trials), animal-plant (NOGO trials), plant-plant (IGNORE trials), and plant-human (NOVEL trials). The trials were grouped into four blocks. In each block a unique set of five animal stimuli, five plant stimuli and five human stimuli was selected. Each block consisted of a pseudo-random presentation of 100 stimuli pairs with equal probability for each trial category.

The task was to press a button as fast as possible in response to GO trials.

According to the task design, two preparatory sets were distinguished in the trials. In the "Continue set" a picture of an animal is presented as the first stimulus and the subject is supposed to prepare to respond. In the "Discontinue set" a picture of a plant is presented as the first stimulus and the subject does not need to prepare to respond.

During the task, subjects were seated in a comfortable chair, 1.5 m in front of a computer screen. The stimuli were presented on a 17 inch monitor using the Psytask (Mitsar Ltd.) software.

The primary outcome was change in score on the QEEG Rating Scale (AMEN questionnaire). The ERP and questionnaire/behavioural assessments will be made at baseline (before stimulation)and 3 months after stimulation.

This study involved 30 subjects, all aged between 7 and 13. All have been diagnosed with ADHD by a medical professional.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Non-Randomized
Intervention Model:
Factorial Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Implications of Electrophysiological ADHD Endophenotypes to Predict Response to Transcranial Direct-Current Stimulation
Study Start Date :
Jun 1, 2012
Actual Primary Completion Date :
Dec 1, 2012
Actual Study Completion Date :
Dec 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: active tDCS

The patients with ADHD received electro-stimulation at 20 sessions with 2 mAmp 1 session per day alternative days. The investigators used an ERP analysis derived of 20 channel EEG recordings during resting state and visual CPT to define the tDCS site and polarity at refractory ADHD patients to conventional treatments. Time courses, topography and amplitude of ERPs, correlated with clinical scores, were compared with the controls average (data base)to guide the selection of personal tDCS parameters. The following relation shown how many patients were submitted to intervention in each electrode, according to their polarity: Anodal tDCS: T5, T6, etc. Cathodal tDCS: T5, T6, etc.

Device: Active tDCS
tDCS applied to left dorsolateral prefrontal scalp area through a saline-soaked pair of surface sponge electrodes (35 cm2). The anode electrode was placed over F3 (based on the 10-20 International EEG System) of each subject. The cathode was placed over the contralateral mastoid area. A constant current of 1.1 mA was applied for 25 min/day (administered for 12 alternated days).
Other Names:
  • Chattanooga Iontophoresis
  • No Intervention: controls

    Healthy people that not receive tDCS

    Outcome Measures

    Primary Outcome Measures

    1. Clinical Assessment (Amen Questionnaire) [From September to December 2012]

      The Amen Attention Deficit Disorder (ADD) Type Questionnaire is a 71-question self-test that evaluates the ADD syndrome. 0 never, 1 rarely, 2 Occasionally, 3 Often and 4 Very Often. Consists of a series of questions that evaluate five brain systems: basal ganglia (23 items), Cingular System (17 items), Temporal System (16 items), Prefrontal Cortex (24 items) and deep limbic system (20 items). Each system has a maximum score of 4, and if this punctuation is greater than 1.7 it is possible that the system is deviated from normality and implicated in AD/HD behavior. The minimal average score is 5 (Best) and the maximum is 20 (Worst). More than four is suspicious of diagnosis, six or more of a score of three or four is needed to make diagnosis. Meets the criteria for inattentiveness (six or more on questions 1-14) and also scores six or more on the cingular system questions (24-36 items), over-focused ADD subtype is suspected.

    Secondary Outcome Measures

    1. Event-related Potentials Amplitude (ERPs) [From September to December 2012]

      ERPs to the GO/NOGO task will be examined for changes as a result of treatment. Assessments were made at baseline (before stimulation), after the 10-12 days of stimulation, and at 1 and 3 months after stimulation. Event related potentials (ERP) generated from a visual continuous performance task (VCPT) are employed to access the early stages of information processing (Mueller et al., 2011; Kropotov, 2008) and performing at a GO/NOGO paradigm may be used to study the mechanisms of the brain's executive functions (Falkenstein et al., 1995). Amplitude and latency of ERP activity recorded from a subject can be compared to normalized databases to predict a possible hyper or hypo function of cerebral circuits. These ERP were recorded on 19 separeted channels according international 10-20 system. Electrode names are derived by brain lobule which is is located below and position, e.g., Pz is Parietal on position zero (midline) and Cz is Central Midline.

    2. Event-related Potentials Latency (ERPs) [From September to December 2012]

      ERPs to the GO/NOGO task will be examined for changes as a result of treatment. Assessments were made at baseline (before stimulation), after the 10-12 days of stimulation, and at 1 and 3 months after stimulation. Event related potentials (ERP) generated from a visual continuous performance task (VCPT) are employed to access the early stages of information processing (Mueller et al., 2011; Kropotov, 2008) and performing at a GO/NOGO paradigm may be used to study the mechanisms of the brain's executive functions (Falkenstein et al., 1995). Amplitude and latency of ERP activity recorded from a subject can be compared to normalized databases to predict a possible hyper or hypo function of cerebral circuits. These ERP were recorded on 19 separeted channels according international 10-20 system. Electrode names are derived by brain lobule which is is located below and position, e.g., Pz is Parietal on position zero (midline) and Cz is Central Midline.

    3. Reaction Time (Behavior Task) [From September to December 2012]

      All subjects performed a Visual continuous performance task (VCPT) with GO/NOGO paradigm. It consists of three types of stimuli: 1) twenty animals (A), 2) twenty images of different plant (P), 3) Twenty images of people of different professions (H) which is present with an artificial sound called "Novel" 20msec and.Thus, each pair of stimulus is presented for 100 milliseconds, at intervals of one second of duration between each block. The objective of is to press a button as quickly as possible while observing the pairs AA, situation called GO, while trying not to press when observes other types of pairs. This latency of response (reaction time) was mensured. Pairs are called GO(AA) NOGO(AP), IGNORE(PP) and NOVEL(PH + Sound). Errors by omission (lack of response in test GO) and by commission (lack of suppression in NOGO test) were be automatically counted for each subject.

    4. Number of Omission and Commission Errors of Behavior Task [From September to December 2012]

      After VCPT task, errors by Omission (lack of response in test GO) and by commission (lack of suppression in NOGO and NOVELTY test) were automatically counted for each subject.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    8 Years to 68 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion criteria:
    1. ADHD diagnosis.

    2. Age between 7 and 65 years.

    3. Comorbidities were no reason for subject exclusion.

    Exclusion criteria:
    1. Presence of psychosis.

    2. Subjects taking medication,they had refrained from taking methylphenidate during 24 hours before testing.

    3. Subjects taking other psychotropics were not included in the study.

    4. Subjects which had suffered of a head injury with subsequent loss of consciousness, and subjects suffering from neurological or systemic medical diseases were excluded from the study.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Murcia University, Psychology School Murcia Spain 30100

    Sponsors and Collaborators

    • Spanish Foundation for Neurometrics Development

    Investigators

    • Study Chair: Moises Aguilar Domingo, Brainmech Foundation

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Spanish Foundation for Neurometrics Development
    ClinicalTrials.gov Identifier:
    NCT01649232
    Other Study ID Numbers:
    • vpradtdcs0102012
    • NCT01755793
    First Posted:
    Jul 25, 2012
    Last Update Posted:
    May 5, 2014
    Last Verified:
    Apr 1, 2014
    Keywords provided by Spanish Foundation for Neurometrics Development

    Study Results

    Participant Flow

    Recruitment Details Subjects were screened and enrolled at 3 clinics in Spain
    Pre-assignment Detail
    Arm/Group Title Active tDCS Controls
    Arm/Group Description Transcranial Direct-Current Stimulation. Patients with ADHD that receive electro-stimulation 20 sessions with 2 mAmp 1 session per day alternative days. 55 % of subjects led the anode in temporal lobe (60% right temporal lobe and 40% in left temporal lobe). 8 % of subjects led de anode in parietal lobe (80 % in left hemisphere), and the rest of subjets 37 % of them led the anodo in frontal and prefrontal lobe (55 % in right frontal lobe and 45 % in left frontal lobe). Healthy people that not receive tDCS
    Period Title: Overall Study
    STARTED 30 30
    COMPLETED 28 30
    NOT COMPLETED 2 0

    Baseline Characteristics

    Arm/Group Title Active tDCS Controls Total
    Arm/Group Description Transcranial Direct-Current Stimulation. Patients with ADHD that receive electro-stimulation 20 sessions with 2 mAmp 1 session per day alternative days Healthy people that not receive tDCS Total of all reporting groups
    Overall Participants 30 30 60
    Age (Count of Participants)
    <=18 years
    19
    63.3%
    14
    46.7%
    33
    55%
    Between 18 and 65 years
    11
    36.7%
    16
    53.3%
    27
    45%
    >=65 years
    0
    0%
    0
    0%
    0
    0%
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    20.06
    (13.03)
    33.12
    (22.80)
    25.14
    (18.09)
    Sex: Female, Male (Count of Participants)
    Female
    9
    30%
    12
    40%
    21
    35%
    Male
    21
    70%
    18
    60%
    39
    65%
    Region of Enrollment (participants) [Number]
    Spain
    30
    100%
    30
    100%
    60
    100%

    Outcome Measures

    1. Primary Outcome
    Title Clinical Assessment (Amen Questionnaire)
    Description The Amen Attention Deficit Disorder (ADD) Type Questionnaire is a 71-question self-test that evaluates the ADD syndrome. 0 never, 1 rarely, 2 Occasionally, 3 Often and 4 Very Often. Consists of a series of questions that evaluate five brain systems: basal ganglia (23 items), Cingular System (17 items), Temporal System (16 items), Prefrontal Cortex (24 items) and deep limbic system (20 items). Each system has a maximum score of 4, and if this punctuation is greater than 1.7 it is possible that the system is deviated from normality and implicated in AD/HD behavior. The minimal average score is 5 (Best) and the maximum is 20 (Worst). More than four is suspicious of diagnosis, six or more of a score of three or four is needed to make diagnosis. Meets the criteria for inattentiveness (six or more on questions 1-14) and also scores six or more on the cingular system questions (24-36 items), over-focused ADD subtype is suspected.
    Time Frame From September to December 2012

    Outcome Measure Data

    Analysis Population Description
    The number of participants needed for study completion is between 20 and 40 for pilot study if it is homogeneous in patients with clinical signs and symptoms, to test efficacy and safety of noninvasive Brain Stimulation.
    Arm/Group Title Active tDCS Control Group
    Arm/Group Description Transcranial Direct-Current Stimulation. Patients with ADHD that receive electro-stimulation 20 sessions with 2 mAmp 1 session per day alternative days Healthy people that not receive tDCS
    Measure Participants 30 30
    Amen Average Scale Pre_tDCS
    9.85
    (1.55)
    3.55
    (1.20)
    Amen Average Scale Post_tDCS at 3 months
    5.15
    (1.83)
    3.54
    (1.21)
    2. Secondary Outcome
    Title Event-related Potentials Amplitude (ERPs)
    Description ERPs to the GO/NOGO task will be examined for changes as a result of treatment. Assessments were made at baseline (before stimulation), after the 10-12 days of stimulation, and at 1 and 3 months after stimulation. Event related potentials (ERP) generated from a visual continuous performance task (VCPT) are employed to access the early stages of information processing (Mueller et al., 2011; Kropotov, 2008) and performing at a GO/NOGO paradigm may be used to study the mechanisms of the brain's executive functions (Falkenstein et al., 1995). Amplitude and latency of ERP activity recorded from a subject can be compared to normalized databases to predict a possible hyper or hypo function of cerebral circuits. These ERP were recorded on 19 separeted channels according international 10-20 system. Electrode names are derived by brain lobule which is is located below and position, e.g., Pz is Parietal on position zero (midline) and Cz is Central Midline.
    Time Frame From September to December 2012

    Outcome Measure Data

    Analysis Population Description
    The number of participants needed for study completion is between 20 and 40 for pilot study if it is homogeneous in patients with clinical signs and symptoms, to test efficacy and safety of noninvasive Brain Stimulation.
    Arm/Group Title Active tDCS Controls Active tDCS at 3 Months Controls at 3 Months
    Arm/Group Description Transcranial Direct-Current Stimulation. Patients with ADHD that receive electro-stimulation 20 sessions with 2 mAmp 1 session per day alternative days Healthy people that not receive tDCS Transcranial Direct-Current Stimulation. Patients with ADHD that receive electro-stimulation 20 sessions with 2 mAmp 1 session per day alternative days Healthy people that not receive tDCS
    Measure Participants 30 30 30 30
    Pz GO amplitude
    6.07
    (2.20)
    5.40
    (2.28)
    4.96
    (2.28)
    4.77
    (2.12)
    Cz NOGO amplitude
    9.22
    (3.59)
    7.01
    (4.52)
    7.23
    (2.49)
    7.21
    (2.19)
    3. Secondary Outcome
    Title Event-related Potentials Latency (ERPs)
    Description ERPs to the GO/NOGO task will be examined for changes as a result of treatment. Assessments were made at baseline (before stimulation), after the 10-12 days of stimulation, and at 1 and 3 months after stimulation. Event related potentials (ERP) generated from a visual continuous performance task (VCPT) are employed to access the early stages of information processing (Mueller et al., 2011; Kropotov, 2008) and performing at a GO/NOGO paradigm may be used to study the mechanisms of the brain's executive functions (Falkenstein et al., 1995). Amplitude and latency of ERP activity recorded from a subject can be compared to normalized databases to predict a possible hyper or hypo function of cerebral circuits. These ERP were recorded on 19 separeted channels according international 10-20 system. Electrode names are derived by brain lobule which is is located below and position, e.g., Pz is Parietal on position zero (midline) and Cz is Central Midline.
    Time Frame From September to December 2012

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Active tDCS Control Group Active tDCS at 3 Months Control Group at 3 Months
    Arm/Group Description Transcranial Direct-Current Stimulation. Patients with ADHD that receive electro-stimulation 20 sessions with 2 mAmp 1 session per day alternative days Healthy people that not receive tDCS Transcranial Direct-Current Stimulation. Patients with ADHD that receive electro-stimulation 20 sessions with 2 mAmp 1 session per day alternative days Healthy people that not receive tDCS
    Measure Participants 30 30 30 30
    Pz GO latency
    323.78
    (10.60)
    324.44
    (16.49)
    321.56
    (13.33)
    326.21
    (15.11)
    Cz NOGO latency
    348.67
    (17.89)
    354.00
    (15.17)
    348.22
    (16.38)
    352.17
    (14.91)
    4. Secondary Outcome
    Title Reaction Time (Behavior Task)
    Description All subjects performed a Visual continuous performance task (VCPT) with GO/NOGO paradigm. It consists of three types of stimuli: 1) twenty animals (A), 2) twenty images of different plant (P), 3) Twenty images of people of different professions (H) which is present with an artificial sound called "Novel" 20msec and.Thus, each pair of stimulus is presented for 100 milliseconds, at intervals of one second of duration between each block. The objective of is to press a button as quickly as possible while observing the pairs AA, situation called GO, while trying not to press when observes other types of pairs. This latency of response (reaction time) was mensured. Pairs are called GO(AA) NOGO(AP), IGNORE(PP) and NOVEL(PH + Sound). Errors by omission (lack of response in test GO) and by commission (lack of suppression in NOGO test) were be automatically counted for each subject.
    Time Frame From September to December 2012

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Active tDCS Group Control Group Active tDCS at 3 Months Control Group at 3 Months
    Arm/Group Description Transcranial Direct-Current Stimulation. Patients with ADHD that receive electro-stimulation 20 sessions with 2 mAmp 1 session per day alternative days Healthy people that not receive tDCS l Direct-Current Stimulation. Patients with ADHD that receive electro-stimulation 20 sessions with 2 mAmp 1 session per day alternative days Healthy people that not receive tDCS
    Measure Participants 30 30 30 30
    Reaction Time Before tDCS
    466.95
    (109.70)
    354.68
    (39.02)
    444.65
    (110.56)
    356.58
    (40.01)
    Reaction time after tDCS
    467.04
    (124.44)
    352.29
    (35.49)
    412.49
    (98.41)
    351.27
    (35.02)
    5. Secondary Outcome
    Title Number of Omission and Commission Errors of Behavior Task
    Description After VCPT task, errors by Omission (lack of response in test GO) and by commission (lack of suppression in NOGO and NOVELTY test) were automatically counted for each subject.
    Time Frame From September to December 2012

    Outcome Measure Data

    Analysis Population Description
    The number of participants needed for study completion is between 20 and 40 for pilot study if it is homogeneous in patients with clinical signs and symptoms, to test efficacy and safety of noninvasive Brain Stimulation.
    Arm/Group Title Active tDCS Control Group
    Arm/Group Description Transcranial Direct-Current Stimulation. Patients with ADHD that receive electro-stimulation 20 sessions with 2 mAmp 1 session per day alternative days Healthy people that not receive tDCS
    Measure Participants 30 30
    Omission Errors pre tDCS GO cues
    11.22
    (10.64)
    1.07
    (1.27)
    Omission Errors post tDCS at 3 months GO cues
    12.22
    (16.54)
    1.04
    (1.29)
    Comission Errors pre tDCS NOGO cues
    0.83
    (3.34)
    0.04
    (0.19)
    Comission Errosr post tDCS at 3 months NOGO cues
    0.30
    (1.02)
    0.04
    (0.19)

    Adverse Events

    Time Frame From September to December 2012
    Adverse Event Reporting Description The adverse events are reported by nurse like at the end of every session.
    Arm/Group Title Active tDCS Controls
    Arm/Group Description Transcranial Direct-Current Stimulation. Patients with ADHD that receive electro-stimulation 20 sessions with 2 mAmp 1 session per day alternative days Healthy people that not receive tDCS
    All Cause Mortality
    Active tDCS Controls
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total / (NaN) / (NaN)
    Serious Adverse Events
    Active tDCS Controls
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/30 (0%) 0/30 (0%)
    Other (Not Including Serious) Adverse Events
    Active tDCS Controls
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 3/30 (10%) 0/30 (0%)
    General disorders
    fatigue or nausea 2/30 (6.7%) 2 0/30 (0%) 0
    Nervous system disorders
    headache 3/30 (10%) 3 0/30 (0%) 0
    headedness / dizziness 3/30 (10%) 3 0/30 (0%) 0

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    All Principal Investigators ARE employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Dr. Moises Aguilar-Domingo, Chairman of Spanish Neurometrics Foundation
    Organization Spanish Neurometrics Foundation
    Phone +34 634548720
    Email moises.aguilar@gmail.com
    Responsible Party:
    Spanish Foundation for Neurometrics Development
    ClinicalTrials.gov Identifier:
    NCT01649232
    Other Study ID Numbers:
    • vpradtdcs0102012
    • NCT01755793
    First Posted:
    Jul 25, 2012
    Last Update Posted:
    May 5, 2014
    Last Verified:
    Apr 1, 2014